Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy	Ear Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neurologic Manifestations, Otorhinolaryngologic Neoplasms, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, acoustic neuroma, cranial nerve neoplasm, cranial nerve neuropathy, hearing disorder, hearing loss disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroma, otorhinolaryngologic disease, peripheral nervous system neoplasm, primitive neuroectodermal tumor, retrocochlear disease, schwannoma, vestibulocochlear nerve disorder	Enrolling by invitation	Not stated	2026-07-16		NCT07503613

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Akouos, Inc.	4
Eli Lilly and Company	370

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Texas Southwestern	Dallas	United States	73